The bullous keratopathy treatment market is projected to experience substantial growth over the coming decade, driven by an aging population, increasing prevalence of cataract surgeries, glaucoma procedures, and novel pharmaceutical interventions from key players such as Aurion Biotechnologies, Emmecell, Trefoil Therapeutics, and Cellusion, among others. Bullous Keratopathy Market Insights,...